Non Invasive Hemodynamic Monitors Are The New Trend In Medical Equipment
The Indian healthcare market has put itself on the global map today. Rapid technological advancements and adoption of digital modes have made it eligible to compete alongside global giants in the competition to provide the best healthcare service.
The hemodynamic systems market is no alien to this. The global hemodynamic monitoring systems market is expanding rapidly, with one report from industryarc.com sizing it at $ 2.27 billion by 2023.
Invasive technology is continuously being scrutinized for its many potential complications, which has led researchers to introduce new technologies in the form of minimally invasive and non-invasive monitoring systems. The demand for these products is expected to grow continuously, at an CAGR greater than the average CAGR of the hemodynamic market.
What are the Hemodynamic Monitors?
Hemodynamic monitoring measures the blood pressure inside the veins, heart, and arteries. It also measures blood flow and how much oxygen is in the blood. In other words, it is a way to see how well the heart is working.
Why and When is Hemodynamic Monitoring done?
Small changes in the heart’s functioning have lasting impacts on the body at a future interval. Detecting these small changes early by testing samples of blood from deep inside the body helps doctors to know whether you need blood or fluid transfusions
Hemodynamic monitoring may be done if you are in intensive care recovering from a heart attack or if you have fluid around your heart. For critically ill patients, continuous hemodynamic monitoring is a matter of life and death
Non-Invasive/ Minimally Invasive Hemodynamic Monitoring Systems
These hemodynamic monitoring systems facilitate painless diagnosis and reduce the risk of blood-borne infections in patients. In addition, these systems are easier to use (as compared to invasive systems) and can be operated by a nurse in the absence of a specialist/doctor.
One such minimally/non-invasive Hemodynamic Monitor is made by renowned UK-based manufacturer LiDCO, the LiDCOrapid, with minimally-invasive monitoring via the standard radial arterial line and one cost-effective disposable.
Its patented PulseCO algorithm remains unchanged for 15 years since its launch in 2001. The algorithm is scaled to each patient with the nomogram using age, height, and weight, with its performance explored in the following patient populations:
- General surgery patients
- Hyperdynamic liver transplantation patients
- Off-pump cardiac surgery patients
- On-pump cardiac surgery
- Post-operative care
- General intensive care patients and
- Heart failure patients
The hemodynamic parameters which it covers are:
- Pressures – MAP, Systolic, and Diastolic
- Heart Rate
- Trending stroke volume, cardiac output and systemic vascular resistance (SVR)
- Dynamic preload parameters – pulse pressure variation (PPV) and stroke volume variation (SVV)
- Event response – tracks % response in CO, SVR, and SV during an intervention such as a fluid challenge
The LiDCOrapid is designed to support your clinical decision making, with easy interpretation of trends from the start of monitoring, which can be customized to the parameters you need. Its validated PulseCO algorithm reliably tracks hemodynamic changes in the presence of inotropes and vasoactive drugs. It is ideal for fluid and drug management across departments, including the ICU department.
From the ED to the OR to Critical Care and other High Care departments. LiDCOrapid has the flexibility to enable continuity of measurement across patient acuity levels.